CJEU ‘shuts door’ on SPCs for second medical uses

10-07-2020

Rory O'Neill

CJEU ‘shuts door’ on SPCs for second medical uses

nitpicker / Shutterstock.com

The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.


CJEU, SPCs, Santen, Arnold & Porter, Beatriz San Martin, Neurim, supplementary protection certificates, marketing authorisation, MA

LSIPR